Infectious Diseases calls for papers / publications

Call for Papers for a Special Issue of the Journal of Clinical Nursing: Sexual and Reproductive Health

The issue of sexual and reproductive health is a major area of clinical practice. It encompasses a broad range of topics – sexuality, sexual behavior, altered body image, sexual and reproductive pathologies and infections, HIV/AIDS, abortion, sexual abuse as well as sexual health services, sex education and the impact of illness, social deprivation and age upon sexuality and sexual expression. Nurses are increasingly involved in work with patients, clients and communities that have sexual and reproductive needs – developing a holistic approach to care is essential, as well as increasing the evidence base for sexual and reproductive health interventions. This special issue aims to make a substantial contribution to this evidence base and also celebrate the wide ranging nature of sexual and reproductive health nursing practice.

Scope Researchers, practitioners and educators are invited to submit a manuscript based on a research study, literature review or discursive topic related to any area of Sexual and Reproductive health that has implications for nursing practice.

Manuscripts are especially welcome in the following areas (although other papers will be considered):

Child and adolescent sexual health issues, HIV/AIDS, Ageing and sexual health, Sexuality and chronic illnesses, Mental health and sexuality, Sex education, Sexual health in marginalized populations, Sexuality and clinical practice, Establishing/evaluating sexual health care or services, sexually transmitted infections, sexual health and pregnancy

All manuscripts will be expected to discuss the implications for clinical practice and adhere to the Journal of Clinical Nursing guidelines for authors available at www.wileyonlinelibrary.com/journal/jocn

Submission The deadline for the receipt of manuscripts is December 2012 with anticipated publication in late 2013. Manuscripts should be submitted online at http://mc.manuscriptcentral.com/jcnur

All papers for the special issue should have the prefix ‘SI – SRH’ before the title of the paper.

Further information
Please contact the editors for this edition; Professor Mark Hayter (m.hayter@hull.ac.uk) or Professor Alice Yuen Loke (hsaloke@inet.polyu.edu.hk).

Call for Papers: International Journal of MCH & AIDS (IJMA)

In our increasingly global world, the health of mothers, infant, and children and youth populations has become an important international health issue. This is particularly important in developing countries where maternal and child health (MCH) is deteriorating and inequalities are growing due to the HIV/AIDS epidemic ravaging populations in developing world. There is an urgent need to collect, document, and disseminate the existing evidence and emerging issues on the intersection between maternal and child health and HIV/AIDS. Above all, non-communicable diseases threaten the fragile gains made in addressing precarious state of maternal and child health in developing countries.

The International Journal of MCH and AIDS (IJMA) provides a platform through which researchers, as well as program and policy makers, can learn about the various factors that contribute to the health and well-being of mothers, infants, children, and adults and how the HIV/AIDS is decimating the gains in those sectors. The journal focuses on empirical findings from low and middle-income countries exploring trends and patterns at international, national, and local levels. Research articles and rigorous meta-analyses are welcome. Ideas for review articles on MCH and HIV/AIDS in developing countries will be considered. The topics to be covered in the journal include, but are not limited to:

Life expectancy, cause-specific mortality, and human development

Maternal, infant, child, and youth mortality and morbidity in developing countries

Determinants and consequences of childhood and adolescent obesity and sedentary behaviors

Quality of life and mental health disparities affecting MCH and HIV/AIDS populations

Social, behavioral, and biological determinants of MCH and HIV/AIDS and well-being

Disparities in health and well-being based on gender, race, ethnicity, immigrant status, social class, education, income, disability status, etc.

Region and/or country specific studies

Cross-national research on MCH and HIV/AIDS issues across the world

Issues of resilience among populations impacted by HIV/AIDS

Applications of surveillance, trend, and multilevel methods, and use of novel approaches in both quantitative and qualitative research studies

Book reviews on (national or cross-national) MCH and HIV/AIDS issues and social determinants of health.

Before submitting their manuscripts, prospective authors should carefully read the journal’s Author Instructions, which are located here http://www.mchandaids.org/?page_id=96

Manuscripts are accepted on a rolling basis. Manuscripts that do not meet the immediate deadline of a particular issue are automatically considered for the next issue. Authors will receive an email confirmation acknowledging receipt of their manuscripts within three days of successful manuscript submission.

If you have any questions please visit or email us:

Website: www.mchandaids.org
Email: editorinchief@mchandaids.org

Call for Papers for a Special Issue of Eurosurveillance: Surveillance and Epidemiology of Leishmaniasis in Europe

Eurosurveillance invites authors to submit papers for a special issue on the surveillance and epidemiology of leishmaniasis in Europe.

Leishmaniasis, a vector-borne disease transmitted by sand flies, is endemic in southern European countries. Autochthonous cases in Europe are mainly due to infection with Leishmania infantum, which causes zoonotic visceral and cutaneous leishmaniasis. L. tropica, endemic only in Greece with a sporadic pattern, causes anthroponotic cutaneous leishmaniasis. Dogs are the main reservoir for L. infantum. Most reported cases have visceral leishmaniasis. A publication in 2008, in Emerging Infectious Diseases [1], estimated that annually around 700 new clinical cases of leishmaniasis are reported in European Union (EU) countries. Asymptomatic cases are thought to be many more, with an estimated ratio of >100 asymptomatic:1 clinical case [2]. Many of the EU countries where the disease is endemic are tourist destinations and there is evidence that a number of leishmaniasis cases diagnosed in non-endemic countries are imported from within the continent. The disease is notifiable in a number of endemic and non-endemic countries in Europe; however, surveillance varies and under-reporting appears to be frequent, especially for the benign forms of cutaneous leishmaniasis.

The aim of the special issue is to contribute to the existing body of evidence and to make available data that can help paint a better picture of the epidemiological situation and burden of autochthonous leishmaniasis in Europe.

We invite interested scientists and public health experts to share their surveillance data, findings and views and submit original papers for peer review and possible publication.

Topics of interest include, but are not limited to:

results from surveillance of visceral and cutaneous leishmaniasis in endemic and non-endemic countries, including trends in age groups affected and the impact of HIV co-infection, organ transplantation, and therapies of immunological disorders on the development and outcome of disease;
information on the distribution of the vector and reservoir;
analysis of treatment-associated costs;
control measures implemented successfully to stop the spread of disease;
issues related to the detection and identification of cases.

The submission deadline is 15 July 2012. If you would like to submit a paper or ask for more information, please see our instructions for authors regarding article formats: http://www.eurosurveillance.org/Public/ForAuthors/ForAuthors.aspx#article and contact the editorial team at eurosurveillance@ecdc.europa.eu.

References

Dujardin JC, Campino L, Cañavate C, Dedet JP, Gradoni L, Soteriadou K, et al. Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis. 2008;14(7):1013-8.
Michel G, Pomares C, Ferrua B, Marty P. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 2011;119(2-3):69-75.

Call for Papers for a Focus Issue of Phytopathology on Food Safety: Human Pathogens on Plants

Article Submission Deadline: August 31, 2012

The special issue will focus on articles that contribute fundamental knowledge of the ecology of foodborne human pathogens on plants, include their fitness on plants, plant-microbe and intermicrobial interactions, and various aspects of plant biology that affect human pathogen colonization and survival.

Benefits to Authors

A focus issue offers the author multiple benefits. A single-topic issue gives scientists an opportunity to publish in a “Focus” issue alongside the related work of peers to highlight the progress being made. This issue will include review articles on the topic by leading scientists in this research area.

The Food Safety: Human Pathogens on Plants Focus Issue will be widely promoted and is expected to be highly cited, giving authors maximum exposure. Articles will be submitted to CrossRef, allowing citation tracking and connectivity as this research area moves forward in Phytopathology and other scientific journals. Articles will also be indexed by ISI Web of Science, PubMed and other important access portals. Submitted papers will be reviewed by an outstanding editorial board and a caring, professional editorial staff dedicated to publishing at the highest standard of quality.

If you are working on research of this type, submit your papers to Phytopathology and note that you would like to be considered for the Special Food Safety Focus Issue. Please submit your paper online at: http://mc.manuscriptcentral.com/phytopathology by August 31st, 2012.

For more information about the scope of this issue, please contact George Sundin.

Call for Submissions: Special Issue of the Journal of HIV/AIDS & Social Services: HIV Care and Prevention in Adolescents and Emerging Adults

Adolescence is a time often marked by experimentation, development of one’s racial and sexual identity, risk taking, and vulnerability. Consequently, emerging adulthood can be characterized as a period of continued change in terms of home, school, work, and relationship domains. Adolescents and young adults (ages 13 to 29) currently account for the largest percentage (39%) of new HIV infections in the United States compared to other age groups. HIV incidence in this group disproportionately affects young gay and bisexual men and young African Americans. Behavioral factors found to be associated with HIV infection in young persons include early age at sexual initiation, older sex partners, history of sexual abuse, sexually transmitted infections, and substance use. Providers may face challenges in delivering developmentally and culturally appropriate interventions for increasing numbers of young persons entering care systems, and providing treatment regimens that are compatible with diverse lifestyles.

The Journal of HIV/AIDS & Social Services is inviting the submission of papers for a special issue on HIV Care and Prevention in
Adolescents and Emerging Adults.

Papers to be considered for review for this special issue should be submitted beginning April 15, 2012, through August 15, 2012.

Topics of interest include:

. Emergent findings in psychosocial approaches to HIV care and prevention in adolescents and young adults.
. Identifying and addressing special needs of adolescents and emerging adults living with HIV/AIDS, including transitioning to adult HIV care.
. Innovative methods in engaging and retaining young persons in prevention and treatment programming.
. Correlates of adolescents and emerging adults’ sexual risk behavior amenable to service delivery or intervention.
. Developmental approaches to working with adolescents and emerging adults living with HIV/AIDS.
. Innovative programmatic approaches relating to issues of gender, race/ethnicity, sexual orientation, and disability.
. Peer-directed programming targeting adolescents and emerging adults living with HIV/AIDS.
. Emergent issues in the intersection of biomedical and psychosocial approaches to HIV/AIDS in adolescents and young adults, including treatment-as-prevention and preexposure prophylaxis.

Douglas Bruce, PhD, MSW
DePaul University
Dexter Voisin, PhD
University of Chicago
Special Edition Editors

The Journal of HIV/AIDS & Social Services receives all manuscript submissions electronically via their ScholarOne Manuscripts website located at: http://mc.manuscriptcentral.com/whiv. ScholarOne Manuscripts allows for rapid submission of original and revised manuscripts, as well as facilitating the review process and internal communication between authors, editors, and reviewers via a web-based platform. ScholarOne Manuscripts technical support can be accessed via http://scholarone.com/services/support/. If you have any other requests, please contact the journal’s Managing Editor at mikebass@uic.edu.

When you enter your manuscript on ScholarOne, please click on the option that you intend it to be considered for the Special Edition: HIV Care and Prevention in Adolescents and Emerging Adults.

Call for Papers for a Special Issue of Developing World Bioethics: Ethical Considerations in the Use of Anti-Retrovirals for HIV Prevention

Deadline for submissions: 31 July 2012

Guest Editors: Ronald Bayer, Quarraisha Abdool Karim

Evidence-based approaches to reducing sexual transmission of HIV has remained a major challenge in responding to the HIV pandemic. The past 18 months has witnessed a substantial shift in this landscape. Controlled trials have demonstrated that the treatment of individuals with HIV infection reduces the risk of viral transmission to uninfected sexual partners (treatment as prevention). Additional evidence suggests the possibility of providing anti-retroviral medications to uninfected individuals may reduce the risk of acquiring HIV infection from sexual partners (PrEP— Pre-Exposure Prophylaxis).

In view of scarce resources, there will inevitably be a need to prioritize who will get anti-retroviral drugs; those who are sick, those who can transmit HIV, those at risk for acquiring HIV. Research that focuses on the balance between efficiency and equity will be involved. Ethical frameworks for guiding decision-making at the clinical level as well as the macro social policy level will be essential.

Among the questions that will need to be discussed are:

i. What rights claims can uninfected persons make for access to ARVs for prophylactic purposes when millions across the globe are dying from AIDS because they cannot access ARV treatment?

ii. What moral claims can justify the provision of ARV therapy to those who do not yet clinically require treatment as a way of reducing the risks of HIV transmission?

iii. What normative issues are raised in making the determination that there is sufficient evidence to demonstrate the effectiveness of either PrEP or Treatment for Prevention?

iv. How should the social and biological vulnerability of women to HIV infection inform discussion about the allocations of resources for either PrEP or treatment as prevention?

v. If there is a risk that PrEP will increase the risk of drug resistance and compromise treatment options for those already infected, what ethical questions must be confronted?

vi. What conceptions of procedural fairness and inclusiveness should shape decision making processes about these allocation decisions?

vii. How should current research findings inform the ethics of trial design?

viii. Given current evidence what moral issues involving the protection of research subjects should be considered in determining the extent of ancillary services and care that should be provided in prevention trials?

The editors welcome early discussion of brief proposals and/or abstracts by email to:

rb8@mail.cumc.columbia.edu or abdoolq2@ukzn.ac.za.

Upon submission authors should include full contact details and a few lines of autobiographical information in a separate electronic file. We discourage papers of more than 5000 words.

For further submission requirements, format and referencing style, refer to the Author Guidelines on the Developing World Bioethics website: http://wileyonlinelibrary.com/journal/dewb

Manuscripts should be submitted to Developing World Bioethics online at:
http://mc.manuscriptcentral.com/dwb.

Please ensure that you select manuscript type ‘Special Issue’ and state that it is for the ARV Special Issue.

Call for Papers: The Male Body in Medicine and Literature

Following the success of the recent collection The Female Body in Medicine and Literature (LUP 2011) Liverpool University Press have commissioned a companion volume entitled The Male Body in Medicine and Literature. This new collection will provide interdisciplinary essays that will explore the complex intersections between literature and the medical treatment of the male body. We wish to consider the wider cultural ramifications of the representation of the male body, health, sickness, masculinity and ‘manhood’ in order to further our understanding of gender studies, gender politics, science, medicine and literature.

The purpose of this book will be to survey the complex relations between literature and the medical treatment and representation of the male body from 1600 to the present day and we are seeking essays which offer a range of methodologies that will be interdisciplinary in their discussion of medicine of the male body, the cultural representation of male corporeality in sickness and in health, and the wider cultural ramifications of male health, its intersections with masculinity and manhood. We expect the essays to draw on a wide range of topics that have been informed by cross-pollinating disciplines including literature, history of medicine, gender studies and gay fiction. This collection will offer a major new analysis of the medical treatment and cultural representations of the healthy and sick male body from the early modern period to the present. This will be one of the first single-volume books to concentrate on the links between literature and medicine in their shared dedication to understanding the male body. The healthy male body has a complex relationship with ideas of masculinity, manhood and male power; plus, the health and strength of the male body is linked to ideas of nation at times of war and at times of peace; this book will seek to address these issues and more.

Essays might cover, but are not limited to, the following topics:

Male hysteria
Male consumptives
HIV/AIDS
War, conflict and the male body
Virility, fertility and impotence
Male nursing
The working class male body and medical experimentation
Urology
Disability
Mental health and the male body
Sexually transmitted diseases and the male body

Please submit articles for consideration between 5000 – 7000 words to Greta Depledge (depledgeg@aol.com) and Andrew Mangham (a.s.mangham@reading.ac.uk) by 1st December 2012.

Contributors should follow LUP’s house style, details of which can be found on their website:
http://www.liverpool-unipress.co.uk/html/howtopublish.asp

Call for Papers on Criminalizing Contagion

The BMJ Group journals Sexually Transmitted Infections (impact factor 3.029) and the Journal of Medical Ethics (impact factor 1.391), in conjunction with academics at the Centre for Social Ethics and Policy (University of Manchester) and the Health Ethics and Law Network (University of Southampton), would like to publish a collection of articles on the criminalization of disease and sexually transmitted infections. We invite article contributions to be published as part of this themed collection.[1]

Themes

The use of criminal law to respond to infectious disease transmission has far-reaching implications for law, policy and practice. It presupposes co-operation between clinicians and criminal justice professionals, and that people who infect others can be effectively and fairly identified and brought to justice. There is a potentially difficult relationship between criminal justice and public health bodies, whose priorities do not necessarily coincide. We are interested in receiving papers of broad interest to an international readership of medical ethics scholars and practicing clinicians on any of the following topics:

Legislative and policy reform on disease and sexually transmitted infections
Health services and the police: privacy, state interference and human rights
Evidence and ethics: prosecuting ‘infectious’ personal behaviours
Clinicians and the courts: the role of health professionals and criminal justice
The aims of criminalization and public health: a compatibility problem?
International comparative studies on disease and criminalization: policy, practice and legal issues

Publication

1. Up to eight articles will published in a special section in an issue of Sexually Transmitted Infections in 2013.

2. Two articles will be published in a special section in an issue of Journal of Medical Ethics in 2013.

All articles will be blind peer reviewed according to each individual journal’s editorial policies. Final publication decisions will rest with the Editors in Chief: Professor Jackie Cassell (STI) and Professor Julian Savulescu (JME).

Important Dates

Please submit your article to either journal no later than December 14th 2012.

Submission Instructions

For Sexually Transmitted Infections:

Articles for STI should be a maximum of 2,500 words and submitted via the journal’s website: http://sti.bmj.com/. Please choose the special issue ‘Criminalizing Contagion’ during the submission process.

For Journal of Medical Ethics:

Articles for JME should be a maximum of 3,500 words, and submitted via the journal’s website: http://jme.bmj.com/. Please choose the special issue ‘Criminalizing Contagion’ during the submission process.

Further submission instructions are on the journals’ respective websites. If you would like to discuss any aspect of your submission, including possible topics and the journals involved, please contact the guest editors in the first instance: Dr David Gurnham (David.Gurnham@manchester.ac.uk), Dr Catherine Stanton (Catherine.Stanton@manchester.ac.uk) or Dr Hannah Quirk (Hannah.Quirk@manchester.ac.uk).

[1] Some of the contributors may also be invited to present their papers at one of three sessions of a proposed ESRC seminar series on the same topic, to be organised by the guest editors. If funding for the seminar series is awarded by the ESRC (in April 2012), they will take place in winter 2012/13 and summer 2013 (Southampton), and winter 2013/14 and summer 2014 (Manchester).

Journal of the Pediatric Infectious Diseases Society Cover Art Contest

Calling all talented young artists!

JPIDS is soliciting submissions of drawings that will illustrate the covers of our journal, JPIDS.We are looking for submissions that demonstrate unique artistic vision and creativity with a theme that relates to pediatric infectious disease.

Eligibility:

Artwork completed by individuals less than 18 years at the time of composition may submit artwork. Please submit a high quality color photograph or scan of the artwork. Please do not submit original artwork.

Deadline:

Accepted on a rolling basis.

Selection Process:

Submissions with identifiers removed will be reviewed by the JPIDS editorial board. Parents/guardians of the child with the selected artwork will be asked to sign a copyright release form. The artwork selected will be printed on the front cover of the journal and a summary of the subject of the artwork and pediatric infectious disease relevance as well as the artist’s name and hospital affiliation will be printed in the corresponding JPIDS issue. Winners will also receive a print copy of the issue where their artwork is featured.Multiple Submissions: An artist may submit more than one piece at a time. However, only one piece will be selected for any one artist. Previously published work cannot be accepted.

Format:

Please submit an electronic version of the artwork in high resolution as a .gif, .tiff, or .jpeg file.

Instructions:

Please send submissions electronically as file attachments to the JPIDS Editorial Office ( jpids.editorialoffice@oup.com). Please contact Andi Shane ashane@emory.edu with questions.

Please include:

The title of the artwork
The artist’s name, a parent/ guardian’s name, a parent/ guardian’s email address, telephone number, age at the time the artwork was created, the name of the local academic medical center, a less than 25 word description of the artwork, and the artist’s inspiration for creating the artwork.
 

Call for Papers for a Special Issue of Eurosurveillance: the Molecular Epidemiology of Human Pathogens

Eurosurveillance invites authors to submit papers for a special issue on the molecular epidemiology of human pathogens.

As exemplified in the 2011 outbreak of the Shiga toxin-producing Escherichia coli (STEC) O104:H4 strain in Germany, advanced sequencing technologies are being introduced for application in microbiological investigations supporting surveillance and outbreak investigations. In the STEC outbreak, the traditional microbiological methods were used to characterise the outbreak strain for epidemiological investigations, but for the first time, parallel application of advanced technologies enabled the whole genome sequence of multiple isolates of the outbreak strain to be determined just a few days after the outbreak had been detected. While such scientific and technological advances have great potential to increase the resolution and accuracy of microbiological investigations and deepen our understanding of human pathogens and the diseases they cause, various operational issues need to be resolved in order for such advanced techniques to be incorporated into public health practice.

The aim of this special issue is to provide a comprehensive picture of the current thinking on the role and possible opportunities of applying modern molecular microbiology for informing public health action. It follows from the recent consultation organised by the European Centre for Disease Prevention and Control, which initiated discussion on how public health can benefit from the recent advances in molecular microbiology. We invite interested scientists and public health experts to share their findings and views and submit original papers for peer review and possible publication.

Topics of interest include, but are not limited to:

proof-of-principle examples of the use of advanced molecular methods, e.g. for the detection and characterisation of humans pathogens (bacteria, viruses, fungi and protozoa) and for understanding infectious disease dynamics;
issues related to the use of advanced molecular data on human pathogens for surveillance and outbreak investigation: future directions, potential limitations, needs and implications for public health.

Deadline for special issue on the molecular epidemiology of human pathogens extended to 30 June 2012

If you would like to submit a paper or ask for more information, please see our instructions for authors regarding article formats http://www.eurosurveillance.org/Public/ForAuthors/ForAuthors.aspx#article and contact the editorial team at eurosurveillance@ecdc.europa.eu.